Platelet activation: Yet another strike against routine TRANSFUSION

European Heart Journal

Volumn 31, Issue 22, 2010, Pages 2712-2714

  Kumbhani, Dharam J ^a   Bhatt, Deepak L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; HEMOGLOBIN; OXYGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADVERSE OUTCOME; ANEMIA; BLEEDING; BLOOD RHEOLOGY; CORONARY ARTERY PERFORATION; EDITORIAL; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; FLOW CYTOMETRY; HEART VENTRICLE FIBRILLATION; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; MEDICARE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; PLATELET ACTIVATION;

EID: 78649385044     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq268     Document Type: Editorial

References (18)

1. Hébert PC, Van Der Linden P, Biro G, Hu LQ. Physiologic aspects of anemia. Crit Care Clin 2004;20:187-212.
2. Spahn DR, Smith LR, Veronee CD, McRae RL, Hu WC, Menius AJ, Lowe JE, Leone BJ. Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow. J Thorac Cardiovasc Surg 1993;105:694-704.
3. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345: 1230-1236.
4. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ. The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004;32:39-52.
5. Hébert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, Tweeddale M, Pagliarello G, Schweitzer I; Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29:227-234.
6. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555-1562.
7. Bhatt DL. Intensifying platelet inhibition-navigating between Scylla and Charyb-dis. N Engl J Med. 2007;357:2078-2081.
8. Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, Gevorkian N, Pinnow EE, Kent KM, Pichard AD, Satler LF, Weissman NJ, Lindsay J, Fuchs S. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003; 92:930-935.
9. Doyle BJ, Rihal CS, Gastineau DA, Holmes DR Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009;53:2019-2027.
10. Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55:2556-2566.
11. Madjdpour C, Spahn DR, Weiskopf RB. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Crit Care Med. 2006;34 (5 Suppl): S102-S108.
12. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and pro-thrombotic properties of anemia and red blood cell transfusions. J Thromb Throm-bolysis. 2006;21:167-174.
13. Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoa-gulant potential. Circulation 2002; 106:2372-2378.
14. Berezina TL, Zaets SB, Morgan C, Spillert CR, Kamiyama M, Spolarics Z, Deitch EA, Machiedo GW. Influence of storage on red blood cell rheological properties. J Surg Res 2002;102:6-12.
15. Allen BW, Piantadosi CA. How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. Am J Physiol Heart Circ Physiol. 2006;291: H1507-H1512.
16. Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 2002; 106:981-986.
17. Silvain J, Pena A, Gayla G, Brieger D, Bellemain-Appaix A, Chastre T, Vignalou JB, Beygui F, Barthelemy O, Collet JP, Montalescot G. Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J 2010;31:2816-2821. First published on 29 June 2010. doi:10.1093/eurheartj/ehq209.
18. Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152:1-9.